skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [2];  [3];  [3];  [3];  [4];  [2];  [5]
  1. Harvard Medical School, Boston, MA (United States); Broad Inst., Cambridge, MA (United States)
  2. Harvard Medical School, Boston, MA (United States)
  3. Seqirus, Cambridge, MA (United States)
  4. Duke Univ. Medical School, Durham, NC (United States)
  5. Harvard Medical School, Boston, MA (United States); Howard Hughes Medical Inst., Boston, MA (United States)

Circulating influenza viruses evade neutralization in their human hosts by acquiring escape mutations at epitopes of prevalent antibodies. A goal for next-generation influenza vaccines is to reduce escape likelihood by selectively eliciting antibodies recognizing conserved surfaces on the viral hemagglutinin (HA). The receptor-binding site (RBS) on the HA “head” and a region near the fusion peptide on the HA “stem” are two such sites. We describe here a human antibody clonal lineage, designated CL6649, members of which bind a third conserved site (“lateral patch”) on the side of the H1-subtype, HA head. A crystal structure of HA with bound Fab6649 shows the conserved antibody footprint. The site was invariant in isolates from 1977 (seasonal) to 2012 (pdm2009); antibodies in CL6649 recognize HAs from the entire period. In 2013, human H1 viruses acquired mutations in this epitope that were retained in subsequent seasons, prompting modification of the H1 vaccine component in 2017. The mutations inhibit Fab6649 binding. We infer from the rapid spread of these mutations in circulating H1 influenza viruses that the previously subdominant, conserved lateral patch had become immunodominant for individuals with B-cell memory imprinted by earlier H1 exposure. We suggest that introduction of the pdm2009 H1 virus, to which most of the broadly prevalent, neutralizing antibodies did not bind, conferred a selective advantage in the immune systems of infected hosts to recall of memory B cells that recognized the lateral patch, the principal exposed epitope that did not change when pdm2009 displaced previous seasonal H1 viruses.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities Division; National Institutes of Health (NIH)
Grant/Contract Number:
AC02-06CH11357; P01 AI089618; P41 GM103403; S10 RR029205
OSTI ID:
1417383
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 1; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 85 works
Citation information provided by
Web of Science

References (32)

Variation and infectivity neutralization in influenza journal September 2006
Advances in the development of influenza virus vaccines journal February 2015
Germinal Center Selection and the Antibody Response to Influenza journal October 2015
Viral Receptor-Binding Site Antibodies with Diverse Germline Origins journal May 2015
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin journal August 2011
Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin journal June 2016
Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo journal January 2014
Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain journal November 2017
Antibody landscapes after influenza virus infection or vaccination journal November 2014
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection journal January 2011
Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site journal December 2015
Immune history profoundly affects broadly protective B cell responses to influenza journal December 2015
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season journal October 2014
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies journal June 2012
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain journal November 2016
Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements journal July 2014
Epitope-Specific Human Influenza Antibody Repertoires Diversify by B Cell Intraclonal Sequence Divergence and Interclonal Convergence journal August 2011
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus journal March 2010
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells journal May 2012
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study journal May 2012
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors journal January 2013
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation journal April 2014
H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination journal October 2011
XDS journal January 2010
Phaser crystallographic software journal July 2007
Miscellaneous Algorithms for Density Modification journal July 1998
Coot model-building tools for molecular graphics journal November 2004
The Phenix software for automated determination of macromolecular structures journal September 2011
Towards automated crystallographic structure refinement with phenix.refine journal March 2012
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection journal February 2011
Focused antibody response to influenza linked to antigenic drift journal May 2015
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection journal January 2016

Cited By (17)

B cell epitopes in the intrinsically disordered regions of neuraminidase and hemagglutinin proteins of H5N1 and H9N2 avian influenza viruses for peptide‐based vaccine development journal May 2019
A naturally protective epitope of limited variability as an influenza vaccine target journal September 2018
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses journal February 2019
Passive immunization with influenza haemagglutinin specific monoclonal antibodies journal July 2018
Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain journal April 2019
Dynamic Perspectives on the Search for a Universal Influenza Vaccine journal April 2019
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo journal July 2018
Timescales of influenza A/H3N2 antibody dynamics journal August 2018
Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains journal February 2019
The Quest for a Truly Universal Influenza Vaccine journal October 2019
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine journal March 2019
The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses journal April 2018
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen journal February 2019
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen text January 2019
Structural Insights for Anti-Influenza Vaccine Design journal January 2019
Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance journal January 2020
Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection journal June 2018